OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota and short‐chain fatty acid alterations in cachectic cancer patients
Jorne Ubachs, Janine Ziemons, Zita Soons, et al.
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 6, pp. 2007-2021
Open Access | Times Cited: 101

Showing 26-50 of 101 citing articles:

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study
Yingchen Li, Ke Wang, Yuchong Zhang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 16

Gut microbiota in muscular atrophy development, progression, and treatment: New therapeutic targets and opportunities
Shujie Chen, Puxuan Zhang, Huimin Duan, et al.
The Innovation (2023) Vol. 4, Iss. 5, pp. 100479-100479
Open Access | Times Cited: 15

Gut microbiota disturbances in hospitalized older adults with malnutrition and clinical outcomes
Shirley Steffany Muñoz Fernández, Flávia Barreto Garcez, Júlio César Garcia de Alencar, et al.
Nutrition (2024) Vol. 122, pp. 112369-112369
Closed Access | Times Cited: 5

Effects of Different Supplemental Levels of Protease DE200 on the Production Performance, Egg Quality and Cecum Microflora of Laying Hens
Peiran Cai, Shiqi Liu, Yuang Tu, et al.
Journal of Animal Science (2024) Vol. 102
Closed Access | Times Cited: 5

Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients
M. Yuzefpolskaya, Bruno Bohn, Annamaria Ladanyi, et al.
The Journal of Heart and Lung Transplantation (2024) Vol. 43, Iss. 9, pp. 1395-1408
Open Access | Times Cited: 5

Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons
Yifeng Wang, Shengguang Ding
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

Targeting Gut Microbiota in Cancer Cachexia: Towards New Treatment Options
Concetta Panebianco, A. Villani, Adele Potenza, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1849-1849
Open Access | Times Cited: 11

Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review
Petra Chaľová, Anton Ťažký, Ľudovít Škultéty, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11

High-throughput sequencing analysis of the characteristics of the gut microbiota in aged patients with sarcopenia
Yiyi Zhang, Ying Zhu, Qin Guo, et al.
Experimental Gerontology (2023) Vol. 182, pp. 112287-112287
Open Access | Times Cited: 11

Aging-Related Sarcopenia: Metabolic Characteristics and Therapeutic Strategies
Y.J. Chen, Jinhui Wu
Aging and Disease (2024)
Open Access | Times Cited: 4

Systemic metabolic crosstalk as driver of cancer cachexia
Elisabeth Wyart, Giovanna Carrà, Elia Angelino, et al.
Trends in Endocrinology and Metabolism (2025)
Closed Access

Analysis of intestinal bacterial carboxylesterase-mediated metabolites and the potential antitumour molecular mechanism of angoroside C
Jian‐Ye Song, Hui Xiang, Ru Feng, et al.
Journal of Asian Natural Products Research (2025), pp. 1-18
Closed Access

Abnormal lipid metabolism in cancer-associated cachexia and potential therapy strategy
Ruoxin Fang, Ling Yan, Zhengkai Liao
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10

Nutritional Mechanisms of Cancer Cachexia
Stephanie L. E. Compton, Steven B. Heymsfield, Justin C. Brown
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 77-98
Open Access | Times Cited: 3

Gut microbiota predict retinopathy in patients with diabetes: A longitudinal cohort study
Xinran Qin, Jiaqi Sun, Shuli Chen, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 3

Role of the Gut Microbiome in Skeletal Muscle Physiology and Pathophysiology
Camille Lefevre, Laure B. Bindels
Current Osteoporosis Reports (2022) Vol. 20, Iss. 6, pp. 422-432
Closed Access | Times Cited: 16

Lipopolysaccharide exacerbates to the migration, invasion, and epithelial‐mesenchymal transition of esophageal cancer cells by TLR4/NF‐κB axis
Zhenyan Peng, Ping Wan, Yali Deng, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 5, pp. 1090-1099
Closed Access | Times Cited: 9

Microbes, metabolites and muscle: Is the gut–muscle axis a plausible therapeutic target in Duchenne muscular dystrophy?
Anthony L. Marullo, Ken D. O’Halloran
Experimental Physiology (2023) Vol. 108, Iss. 9, pp. 1132-1143
Open Access | Times Cited: 9

Polysaccharide of Ganoderma lucidum Ameliorates Cachectic Myopathy Induced by the Combination Cisplatin plus Docetaxel in Mice
Sung–Yu Wu, Chu‐Chyn Ou, Meng‐Lin Lee, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 8

The Association between the Gut Microbiome and Development and Progression of Cancer Treatment Adverse Effects
Amanda S. Maddern, Janet K. Coller, Joanne M. Bowen, et al.
Cancers (2023) Vol. 15, Iss. 17, pp. 4301-4301
Open Access | Times Cited: 8

Scroll to top